GR20010300013T1 - Biologically active composition - Google Patents

Biologically active composition

Info

Publication number
GR20010300013T1
GR20010300013T1 GR20010300013T GR20010300013T GR20010300013T1 GR 20010300013 T1 GR20010300013 T1 GR 20010300013T1 GR 20010300013 T GR20010300013 T GR 20010300013T GR 20010300013 T GR20010300013 T GR 20010300013T GR 20010300013 T1 GR20010300013 T1 GR 20010300013T1
Authority
GR
Greece
Prior art keywords
biologically active
active agent
carrier
active composition
chemical reaction
Prior art date
Application number
GR20010300013T
Other languages
Greek (el)
English (en)
Inventor
Ke Lindahl
H Kan Hagslaett
Catharina Heiman
Rickard Bryland
Original Assignee
Bioglan Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioglan Ab filed Critical Bioglan Ab
Publication of GR20010300013T1 publication Critical patent/GR20010300013T1/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GR20010300013T 1998-05-14 2001-04-30 Biologically active composition GR20010300013T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9801704A SE9801704D0 (sv) 1998-05-14 1998-05-14 Biologically active composition
PCT/SE1999/000823 WO1999058108A1 (en) 1998-05-14 1999-05-12 Biologically active composition

Publications (1)

Publication Number Publication Date
GR20010300013T1 true GR20010300013T1 (en) 2001-04-30

Family

ID=20411318

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20010300013T GR20010300013T1 (en) 1998-05-14 2001-04-30 Biologically active composition

Country Status (20)

Country Link
US (1) US6537576B1 (https=)
EP (1) EP1082102B1 (https=)
JP (1) JP2002514587A (https=)
KR (1) KR100592971B1 (https=)
CN (1) CN1309553A (https=)
AT (1) ATE310500T1 (https=)
AU (1) AU736480B2 (https=)
CA (1) CA2331527C (https=)
DE (2) DE1082102T1 (https=)
ES (1) ES2155048T3 (https=)
GR (1) GR20010300013T1 (https=)
HU (1) HUP0102426A2 (https=)
IL (2) IL139576A0 (https=)
NO (1) NO20005724L (https=)
NZ (1) NZ508073A (https=)
PL (1) PL344051A1 (https=)
SE (1) SE9801704D0 (https=)
TR (1) TR200003589T2 (https=)
WO (1) WO1999058108A1 (https=)
ZA (1) ZA200006474B (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003524652A (ja) * 2000-02-29 2003-08-19 ツァン,ツィエ 改良された経皮薬剤パッチ
KR20090031726A (ko) 2006-06-14 2009-03-27 닥터 레디스 레보러터리즈 리미티드 국소용 조성물
US20080226698A1 (en) * 2007-03-16 2008-09-18 Mylan Technologies, Inc. Amorphous drug transdermal systems, manufacturing methods, and stabilization
EP2349230A2 (en) 2008-10-06 2011-08-03 Mylan Technologies, Inc. Amorphous rotigotine transdermal system
EP3473615B1 (en) 2013-02-28 2022-01-19 Journey Medical Corporation Glycopyrrolate salts
US8558008B2 (en) 2013-02-28 2013-10-15 Dermira, Inc. Crystalline glycopyrrolate tosylate
US9006462B2 (en) 2013-02-28 2015-04-14 Dermira, Inc. Glycopyrrolate salts

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD217989A1 (de) 1983-08-09 1985-01-30 Univ Ernst Moritz Arndt Verfahren zur herstellung einer pharmazeutischen zubereitung
US4940701A (en) 1984-01-25 1990-07-10 Beecham Group P.L.C. Topical drug release system
AR246186A1 (es) 1989-11-17 1994-07-29 Beta Pharm Co Procedimiento para fabricar un dispositivo para administrar estradiol por via transdermica.
SE9502244D0 (sv) * 1995-06-20 1995-06-20 Bioglan Ab A composition and a process for the preparation thereof
US5906830A (en) * 1995-09-08 1999-05-25 Cygnus, Inc. Supersaturated transdermal drug delivery systems, and methods for manufacturing the same
GB2306885B (en) 1995-11-08 1999-07-14 Reckitt & Colmann Prod Ltd Supersaturated Pharmaceutical Compositions

Also Published As

Publication number Publication date
IL139576A0 (en) 2002-02-10
JP2002514587A (ja) 2002-05-21
AU736480B2 (en) 2001-07-26
ZA200006474B (en) 2001-09-04
TR200003589T2 (tr) 2001-03-21
KR20010052348A (ko) 2001-06-25
DE1082102T1 (de) 2001-09-06
EP1082102B1 (en) 2005-11-23
DE69928524T2 (de) 2006-08-10
DE69928524D1 (de) 2005-12-29
SE9801704D0 (sv) 1998-05-14
PL344051A1 (en) 2001-09-24
ES2155048T1 (es) 2001-05-01
CN1309553A (zh) 2001-08-22
NZ508073A (en) 2002-12-20
WO1999058108A1 (en) 1999-11-18
ES2155048T3 (es) 2006-06-16
NO20005724L (no) 2001-01-09
IL139576A (en) 2007-07-04
KR100592971B1 (ko) 2006-06-23
CA2331527C (en) 2010-04-13
US6537576B1 (en) 2003-03-25
HUP0102426A2 (hu) 2002-03-28
EP1082102A1 (en) 2001-03-14
CA2331527A1 (en) 1999-11-18
NO20005724D0 (no) 2000-11-13
ATE310500T1 (de) 2005-12-15
AU4405099A (en) 1999-11-29

Similar Documents

Publication Publication Date Title
CA2215377A1 (en) Controlled delivery compositions and processes for treating organisms in the environment
ZA943640B (en) Synergistically stabilized liquid enzymatic compositions
JPS57192463A (en) Polymer film having maleic anhydride residue
MY115549A (en) Method of making controlled release devices
MY118174A (en) Process for the preparation of microparticles
IL139576A0 (en) Biologically active composition
DE3889385D1 (de) Mikroorganismen enthaltende Düngemittel und Verfahren zu ihrer Herstellung.
EP0145267A3 (en) Method and compositions relating to the activation of fluorescent whitening agents
ZA200006476B (en) Biologically active composition.
EP0302824A3 (en) Moisture activated agricultural composition and method
JPS5687519A (en) Drug pharmaceutical
ES2100807A1 (es) Metodo para la aromatizacion de plasticos.
JPS57126811A (en) Acrylic water-swellable composition
Pagga Biodegradation of Substances at Low Concentrations(Biologischer Abbau von Stoffen bei Geringen Konzentrationen)
Haller Enhanced biological phosphorus removal.
KR860008946A (ko) 수처리 조성물
JPS5382049A (en) Method of treating non-ionic surface active agent containing waste water
CA2025516A1 (en) Selective leach for oxides and therein-contained metals
AU5766790A (en) Liquid polymer composition, and method of use
AU1749001A (en) Standard sample composition and manufacture thereof
TH25177A (th) การปรับปรุงในหรือเกี่ยวข้องกับกรรมวิธีหนึ่ง
KR930012035A (ko) 소마토트로핀을 함유하는 지속성 조성물